121 related articles for article (PubMed ID: 2901357)
1. Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes.
Aulakh CS; Zohar J; Wozniak KM; Hill JL; Murphy DL
Eur J Pharmacol; 1988 Jun; 150(3):239-46. PubMed ID: 2901357
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of short- and long-term lithium treatment on m-CPP-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
Neuroendocrinology; 1993 May; 57(5):869-74. PubMed ID: 8413823
[TBL] [Abstract][Full Text] [Related]
3. Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats.
Aulakh CS; Haass M; Zohar J; Wozniak KM; Hill JL; Murphy DL
Pharmacol Biochem Behav; 1989 Jan; 32(1):37-42. PubMed ID: 2734349
[TBL] [Abstract][Full Text] [Related]
4. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
Aulakh CS; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in rats.
Wozniak KM; Aulakh CS; Hill JL; Murphy DL
Pharmacol Biochem Behav; 1989 May; 33(1):265-7. PubMed ID: 2780783
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats.
Aulakh CS; Zohar J; Wozniak KM; Hill JL; Haass M; Murphy DL
Pharmacol Biochem Behav; 1991 May; 39(1):91-5. PubMed ID: 1924518
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of long-term antidepressant treatments on 8-OHDPAT-induced increases in plasma prolactin and corticosterone in rats.
Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Eur J Pharmacol; 1988 Nov; 156(3):395-400. PubMed ID: 2975226
[TBL] [Abstract][Full Text] [Related]
8. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats.
Aulakh CS; Wozniak KM; Hill JL; Devane CL; Tolliver TJ; Murphy DL
Neuroendocrinology; 1988 Oct; 48(4):401-6. PubMed ID: 2463494
[TBL] [Abstract][Full Text] [Related]
9. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
Mueller EA; Murphy DL; Sunderland T
Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595
[TBL] [Abstract][Full Text] [Related]
10. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.
Ulrichsen J; Partilla JS; Dax EM
Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053
[TBL] [Abstract][Full Text] [Related]
11. [Effect of clorgyline and of alpha-methyl-p-tyrosine on the plasma levels of corticosterone in the rat].
Pinilla J; Montilla P; Clavero R
Rev Esp Fisiol; 1985 Dec; 41(4):411-6. PubMed ID: 2869553
[TBL] [Abstract][Full Text] [Related]
12. Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats.
Mazzola-Pomietto P; Aulakh CS; Huang SJ; Murphy DL
J Pharmacol Exp Ther; 1996 Nov; 279(2):782-9. PubMed ID: 8930184
[TBL] [Abstract][Full Text] [Related]
13. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Bero LA; Kuhn CM
J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276
[TBL] [Abstract][Full Text] [Related]
14. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.
Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL
Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816
[TBL] [Abstract][Full Text] [Related]
15. Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine.
Cohen RM; Aulakh CS; Murphy DL
Eur J Pharmacol; 1983 Oct; 94(1-2):175-9. PubMed ID: 6653658
[TBL] [Abstract][Full Text] [Related]
16. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats.
Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL
J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707
[TBL] [Abstract][Full Text] [Related]
17. Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity.
Aulakh CS; Zohar J; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1989; 98(4):448-52. PubMed ID: 2505284
[TBL] [Abstract][Full Text] [Related]
18. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.
Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL
Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys.
Aloi JA; Insel TR; Mueller EA; Murphy DL
Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T
Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
